Current location - Health Preservation Learning Network - Health preserving recipes - Chinese medicine leading stocks list?
Chinese medicine leading stocks list?
Chinese medicine leading stocks list?

The concept of traditional Chinese medicine leading stock is a leading company stock in the traditional Chinese medicine industry. They usually have rich experience in research and development of traditional Chinese medicine, high-quality products and stable market share. The following small series brings a list of Chinese medicine leading stocks, which is of great benefit to you. Let's have a look.

A list of Chinese medicine leading stocks

The leading stocks of traditional Chinese medicine are: Guangxin Pharmaceutical (3005 19), Angel Pharmaceutical (00210/8), Shenlong Rongfa (300534), Yunnan Baiyao (000538), Tongrentang (600085) and Pien Tze Huang.

Leading stock name Leading stock code belongs to the sector industry category. Related reasons Huangqi Shengmai Yin is the leading biological product of Guangxin Medicine 3005 19 Growth Enterprise Market, which is mainly used for cardiovascular diseases and traumatic diseases, and is a Chinese patent medicine. Indications: deficiency of both qi and yin, heart disease, shortness of breath and other diseases. Other products include Shenjindan capsules and American ginseng oral liquid. Promoting blood circulation and removing blood stasis; The revenue of pharmaceutical industry in 20 19 is 2065438 USD +09.9 10 billion, accounting for more than 95%.

What are the leading stocks in the Chinese medicine sector?

What are the leading stocks of traditional Chinese medicine: Pien Tze Huang1; ② Yunnan Baiyao; 3 Jiuzhitang; ④ Tong Ren Tang; 5 Baiyun Mountain; 6 Jiang Zhong Pharmaceutical; 7 Ma Yinglong. In addition, Chinese medicine stocks include Neptune Bio, Fengyuan Pharmaceutical, Dong 'e Ejiao and Livzon Group. Since the implementation of the policy of "centralized procurement of the fifth batch of drugs" in the second half of last year, the CSI medicine index has been continuously adjusted back by more than 20%, and it has dropped by-14% in the dimension in the past year, while the CSI Chinese medicine index has been "outstanding", with an increase of nearly 40% in the past year, ranking first in the pharmaceutical sector. : 1, Tongrentang (600085): Chinese medicine leading stock. 1October 22nd 10, Tongrentang shares rose 0.6 1% to 33. 1 1 yuan; Within five days, the stock price fell by 1.06%, with a market value of 45.409 billion yuan.

After more than ten years of development, the company has now formed a relatively complete industrial chain with Chinese herbal medicine cultivation, Chinese patent medicine research and development, pharmaceutical logistics and distribution, and pharmaceutical retail as the core.

2. Baiyun Mountain (600332): Chinese medicine leading stock. 654381On October 22nd, the stock price of Baiyun Mountain fell by 0.5% in five days, and the increase since this year has reached 1.7 1%, with the latest price of 29.8 yuan and price-earnings ratio of 16.62.

The company is a Chinese medicine enterprise with the most complete variety, the largest number of Chinese time-honored brands and the largest output value in the domestic Chinese medicine industry. There are more than 400 kinds of traditional Chinese medicines, covering almost all the classifications of traditional Chinese medicines and 45 kinds of national second-class protected traditional Chinese medicines, among which more than 20 kinds are exclusively produced, and more than 0/00 kinds of foreign famous brand pharmaceutical products are exclusively represented. Such as Wang Laoji, Chen Liji, Pan Gaoshou, Jing Xiu Tang, etc. , are well-known century-old stores. Among them, there are 20 exclusive products such as Xiaoke Pill and Huatuo Zaizao Pill. Wang Laoji Herbal Tea, Baoji Pill, Wuji Baifeng Pill and other products are well-known products in South China and Southeast Asia. After five enterprises including Wang Laoji Pharmaceutical and Jingxiutang Pharmaceutical were selected as the first batch of "Chinese Time-honored Brands", three enterprises including Zhong Yi Pharmaceutical were selected as the second batch of "Chinese Time-honored Brands".

3. Pien Tze Huang (600436): Chinese medicine leading stock. 65438+1opening news on October 22nd, Pien Tze Huang recently reported 434.99 yuan, with a turnover of 30 1 10,000 lots, with a total market value of 262.437 billion yuan.

The company was awarded the title of "High-tech Enterprise" by the Ministry of Science and Technology, and passed the re-certification of high-tech enterprises, and was awarded "Top 5 Scientific and Technological Innovation Output of Chinese Medicine Enterprises in China/KLOC-0".

Other Chinese medicine concept stocks include Tianyao Pharmaceutical, Jiudian Pharmaceutical, Erkang Pharmaceutical, Ganyuan Pharmaceutical, Yiling Pharmaceutical, Taiantang Pharmaceutical, Xinbang Pharmaceutical, Jinling Pharmaceutical, Fangsheng Pharmaceutical, Buchang Pharmaceutical, Harbin Pharmaceutical and Magic Pharmaceutical.

What are the leading stocks in the pharmaceutical sector?

The leading stocks in the pharmaceutical sector are Sinopharm, Shanghai Pharmaceutical, Lu Kang Pharmaceutical, China Pharmaceutical and Wohua Pharmaceutical.

First, Wohua Medicine

Wohua Medicine established Weifang Chinese Medicine Factory in Shandong Province on the basis of 1959 1. In February 2002, it was restructured into Weifang Wohua Pharmaceutical Technology Co., Ltd. ... On June 24, 2007, the company's shares were officially listed on the Shenzhen Stock Exchange, becoming the first listed pharmaceutical enterprise in Weifang.

Second, Sinopharm shares

Sinopharm Holdings Pharmaceutical Co., Ltd. was successfully listed on Shanghai Stock Exchange on October 27th, 2002. Sinopharm Group Pharmaceutical Co., Ltd. was established by China Pharmaceutical Group Company. Approved by the State Economic and Trade Commission, it was formally established on199965438+February 2 1.

Third, Shanghai medicine

Shanghai pharmaceutical group co., ltd (stock code: 60 1607) is a state-owned pharmaceutical industry group headquartered in Shanghai. It is one of the few listed pharmaceutical companies in China that is in a leading position in the pharmaceutical products and circulation market, and has been selected as sample stocks of Shanghai Stock Exchange 180 Index and Shanghai and Shenzhen 300 Index.

Fourth, Lu Kang medicine.

Shandong Lu Kang Pharmaceutical Group Co., Ltd. is an important antibiotic production base in China. Lu Kang's predecessor, Jining Antibiotic Factory, was established in 1966. 1984 took the lead in implementing the factory director responsibility system in the whole province, and 1992 was transformed into the first large-scale joint-stock enterprise in Shandong pharmaceutical system. 1997 "Lu Kang pharmaceutical" a shares are listed on the Shanghai stock exchange.

Verb (abbreviation of verb) China medicine

China Pharmaceutical and Health Products Co., Ltd. is a state-owned listed company listed on the Shanghai Stock Exchange (stock abbreviation: "China Pharmaceutical", stock code: 600056).

Top ten leading stocks of traditional Chinese medicine

The top ten leading Chinese medicine stocks are Pien Tze Huang, Yunnan Baiyao, Jiuzhitang, essence pharmaceutical, Tongrentang, Baiyun Mountain, Kangyuan Pharmaceutical, Jiang Zhong Pharmaceutical, Guangyuyuan and Ma Yinglong.

In 20 19, the market scale of medical and health service industry in China reached 4.6 trillion yuan, with 2015-2019 cagr12%, and it is expected to reach 10 trillion yuan in 2030.

Among them, China's traditional Chinese medicine health industry has also grown with the development of medical and health services. In 20 19, the health market scale of Chinese medicine university was 91700 million yuan. According to the in-depth analysis of the traditional Chinese medicine industry and the Research Report on the Guidance of the 13th Five-Year Development Plan, the scale of the traditional Chinese medicine industry is expected to reach 2,242 billion yuan in 2030, and it is expected to be 20 19-2030 CAGR 1 1.3%.

What are the stocks of traditional Chinese medicine concept leading stocks?

Chinese medicine leading stocks include Guangxin Pharmaceutical (3005 19), Angel Pharmaceutical (00210/8), Shenlong Rongfa (300534), Yunnan Baiyao (00538), Tongrentang (600085) and Pien Tze Huang.

Extended information:

1. Other Chinese medicine concept stocks include:

1. Taian Tang: In the past seven trading days, Taian Tang fell by 20.26%, with the highest price of 6.48 yuan, and the total market value fell by 85 1 10,000 yuan, a decrease of 20.26%.

2. Yisheng Pharmaceutical: Looking back on the past seven trading days, Yisheng Pharmaceutical has fallen for six consecutive days. The whole period fell by 9.38%, the highest price was 8.58 yuan, the lowest price was 9. 14 yuan, and * * * sold 40196,600 lots.

3. Yiling Pharmaceutical: The share price of Yiling Pharmaceutical fell 15.08% in recent 7 days, and rose by 2.26% in 2022, with the highest price of 25.76 yuan and the market value of 34.784 billion yuan.